Pharmacokinetics, thrombolytic efficacy and hemorrhagic risk of different streptokinase regimens in heparin-treated acute myocardial infarction
- 1 May 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (17) , 1185-1192
- https://doi.org/10.1016/0002-9149(89)90176-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activityBlood, 1988
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Assessment of Left Ventricular Function in a Randomised Study of Intravenous Anisoylated Plasminogen Streptokinase Activator Complex versus Heparin in Acute Myocardial InfarctionDrugs, 1987
- Activation of the fibrinolytic system during intracoronary streptokinase administrationJournal of the American College of Cardiology, 1987
- High-dose, brief-duration intravenous infusion of streptokinase in acute myocardial infarction: Description of effects in the circulationThe American Journal of Cardiology, 1986
- Coronary artery reperfusion in acute myocardial infarction: Assessment by pre- and postintervention thallium-201 myocardial perfusion imagingThe American Journal of Cardiology, 1985
- Coronary Thrombolysis for Evolving Myocardial InfarctionDrugs, 1984
- Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.Circulation, 1983
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983
- THE MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN. I. INDUCTION AND EFFECTS*Journal of Clinical Investigation, 1959